| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2023-02-21 17:18:25 UTC |
|---|
| HMDB ID | HMDB0015167 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Mercaptopurine |
|---|
| Description | Mercaptopurine is only found in individuals that have used or taken this drug. It is an antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. [PubChem]Mercaptopurine competes with hypoxanthine and guanine for the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) and is itself converted to thioinosinic acid (TIMP). This intracellular nucleotide inhibits several reactions involving inosinic acid (IMP), including the conversion of IMP to xanthylic acid (XMP) and the conversion of IMP to adenylic acid (AMP) via adenylosuccinate (SAMP). In addition, 6-methylthioinosinate (MTIMP) is formed by the methylation of TIMP. Both TIMP and MTIMP have been reported to inhibit glutamine-5-phosphoribosylpyrophosphate amidotransferase, the first enzyme unique to the de novo pathway for purine ribonucleotide synthesis. Experiments indicate that radiolabeled mercaptopurine may be recovered from the DNA in the form of deoxythioguanosine. Some mercaptopurine is converted to nucleotide derivatives of 6-thioguanine (6-TG) by the sequential actions of inosinate (IMP) dehydrogenase and xanthylate (XMP) aminase, converting TIMP to thioguanylic acid (TGMP). |
|---|
| Structure | InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) |
|---|
| Synonyms | | Value | Source |
|---|
| 1,7-Dihydro-6H-purine-6-thione | ChEBI | | 3H-Purine-6-thiol | ChEBI | | 6-MP | ChEBI | | 6-Thiohypoxanthine | ChEBI | | Mercaptopurine anhydrous | Kegg | | Purinethol | Kegg | | 6 MP | HMDB | | 6-Mercaptopurine | HMDB | | Mercaptopurine monohydrate | HMDB | | Mercapurin | HMDB | | MP | HMDB | | 6 Mercaptopurine monohydrate | HMDB | | 6-Mercaptopurine monohydrate | HMDB | | Puri-nethol | HMDB | | 6 Mercaptopurine | HMDB | | GlaxoSmithKline brand OF 6 mercaptopurine | HMDB | | Leupurin | HMDB | | Wellcome brand OF 6-mercaptopurine | HMDB | | 6 Thiohypoxanthine | HMDB | | 6 Thiopurine | HMDB | | Glaxo wellcome brand OF 6 mercaptopurine | HMDB | | GlaxoSmithKline brand OF 6-mercaptopurine | HMDB | | Puri nethol | HMDB | | Wellcome brand OF 6 mercaptopurine | HMDB | | 6-Thiopurine | HMDB | | Glaxo wellcome brand OF 6-mercaptopurine | HMDB | | Mercaptopurina wellcome | HMDB | | Purimethol | HMDB |
|
|---|
| Chemical Formula | C5H4N4S |
|---|
| Average Molecular Weight | 152.177 |
|---|
| Monoisotopic Molecular Weight | 152.015666838 |
|---|
| IUPAC Name | 6,7-dihydro-3H-purine-6-thione |
|---|
| Traditional Name | mercaptopurine |
|---|
| CAS Registry Number | 50-44-2 |
|---|
| SMILES | S=C1N=CNC2=C1NC=N2 |
|---|
| InChI Identifier | InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) |
|---|
| InChI Key | GLVAUDGFNGKCSF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as purinethiones. These are purines in which the purine moiety bears a thioketone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | Purinethiones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Purinethione
- Pyrimidinethione
- Pyrimidine
- Heteroaromatic compound
- Imidazole
- Azole
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organosulfur compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 313 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.74 g/L | Not Available | | LogP | -0.4 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.67 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3812 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.79 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 177.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 685.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 367.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 61.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 259.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 110.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 294.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 248.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 770.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 613.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 38.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 668.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 227.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 391.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 712.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 362.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 314.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Mercaptopurine,1TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 1933.6 | Semi standard non polar | 33892256 | | Mercaptopurine,1TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 2087.1 | Standard non polar | 33892256 | | Mercaptopurine,1TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 2722.5 | Standard polar | 33892256 | | Mercaptopurine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 1871.2 | Semi standard non polar | 33892256 | | Mercaptopurine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 1945.7 | Standard non polar | 33892256 | | Mercaptopurine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 2583.3 | Standard polar | 33892256 | | Mercaptopurine,2TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C | 2074.9 | Semi standard non polar | 33892256 | | Mercaptopurine,2TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C | 2152.7 | Standard non polar | 33892256 | | Mercaptopurine,2TMS,isomer #1 | C[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C | 2394.8 | Standard polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 2160.6 | Semi standard non polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 2325.9 | Standard non polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=C[NH]2 | 2791.6 | Standard polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 2111.4 | Semi standard non polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 2172.4 | Standard non polar | 33892256 | | Mercaptopurine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=C1C(=S)N=C[NH]2 | 2686.6 | Standard polar | 33892256 | | Mercaptopurine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C(C)(C)C | 2432.8 | Semi standard non polar | 33892256 | | Mercaptopurine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C(C)(C)C | 2554.5 | Standard non polar | 33892256 | | Mercaptopurine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=NC(=S)C2=C1N=CN2[Si](C)(C)C(C)(C)C | 2529.4 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Mercaptopurine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-6900000000-6a7f989ad4995b3bfb3b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Mercaptopurine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , negative-QTOF | splash10-0udi-1900000000-80fade3542b1b7a4f542 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , negative-QTOF | splash10-0udi-4900000000-ae3cab845511e09fd7d8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , negative-QTOF | splash10-052f-9400000000-eb3a9e5b93f0954dda1f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , negative-QTOF | splash10-066u-9300000000-e920208db376745577ae | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , negative-QTOF | splash10-014r-9100000000-9452425dda09b342a804 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , positive-QTOF | splash10-000i-0900000000-fb1e1ed0d15536d940b5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , positive-QTOF | splash10-00di-9300000000-ae82c485895af50f18e0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , positive-QTOF | splash10-01ba-9700000000-70542617d846459d1edb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , positive-QTOF | splash10-00kb-9400000000-34922db319d482f338c7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine LC-ESI-QQ , positive-QTOF | splash10-0006-9000000000-7de65dacfd12ff92f5e4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine 40V, Positive-QTOF | splash10-014i-0900000000-f85c1903d3c0e56417e1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine 20V, Positive-QTOF | splash10-0udi-0900000000-ea506d4c3735e8341ab4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Mercaptopurine 10V, Positive-QTOF | splash10-0udi-0900000000-f8b71bfd941d3b3f3373 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 10V, Positive-QTOF | splash10-0udi-0900000000-7a22823f32dc64d60c70 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 20V, Positive-QTOF | splash10-0udi-0900000000-3dac1862e412a02b04c7 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 40V, Positive-QTOF | splash10-0ufr-7900000000-86f3475856644175beb5 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 10V, Negative-QTOF | splash10-0udi-0900000000-65499423bcb28e8ec450 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 20V, Negative-QTOF | splash10-0uk9-0900000000-e72e8a55b92000661bf6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 40V, Negative-QTOF | splash10-01b9-9600000000-b86d5a7c7cd083d92e19 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 10V, Positive-QTOF | splash10-0udi-0900000000-67dad22e2593a56a8777 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 20V, Positive-QTOF | splash10-0udi-0900000000-804445f5cb6f103d3d1d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 40V, Positive-QTOF | splash10-067i-9200000000-91b7dfe5d6dabda4e777 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 10V, Negative-QTOF | splash10-0udi-0900000000-cbc84ccd8657a0abcedc | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 20V, Negative-QTOF | splash10-0udi-4900000000-63ec34a1f43cd509d6ef | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mercaptopurine 40V, Negative-QTOF | splash10-0aor-9000000000-d4dd4afbcb5bdd8e05b5 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|